SCHEMBL22014574

SCHEMBL22014574

CBc1c(F)cccc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA7 P43166 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ CA4 P22748 1/20 0.42
▸ HPGD P15428 2/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850779 0.82 NFE2L2 (0.43) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL29387155 0.73 CA1 (0.50) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL196734 0.73 CA1 (0.50) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL29466747 0.72 — —
SCHEMBL7027663 0.72 — —
SCHEMBL22390 0.72 — —
SCHEMBL29669870 0.71 NFE2L2 (0.50) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL256786 0.71 NFE2L2 (0.48) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL1627720 0.71 NFE2L2 (0.50) NFE2L2L3MBTL1TDP1CA12CA1
SCHEMBL27340979 0.71 NFE2L2 (0.48) NFE2L2L3MBTL1TDP1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102730-A1 IMPROVED SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND AMGEN INC. (US) 2020-05-22 — — WO disclosed
Send feedback